UTIBRON NEOHALER (Novartis Pharmaceuticals Corporation)
Welcome to the PulseAid listing for the UTIBRON NEOHALER drug offered from Novartis Pharmaceuticals Corporation. This Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC],Anticholinergic [EPC],Cholinergic Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Novartis Pharmaceuticals Corporation |
| NON-PROPRIETARY NAME: | indacaterol and glycopyrrolate |
| SUBSTANCE NAME: | INDACATEROL MALEATE; GLYCOPYRROLATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC],Anticholinergic [EPC],Cholinergic Antagonists [MoA] |
| ROUTE: | RESPIRATORY (INHALATION) |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2015-10-29 |
| END MARKETING DATE: | 0000-00-00 |
UTIBRON NEOHALER HUMAN PRESCRIPTION DRUG Details:
| Item Description | UTIBRON NEOHALER from Novartis Pharmaceuticals Corporation |
| LABELER NAME: | Novartis Pharmaceuticals Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 27.5; 15.6(ug/1; ug/1) |
| START MARKETING DATE: | 2015-10-29 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0078-0664_4407913f-f885-4308-a863-5e9b5365ea66 |
| PRODUCT NDC: | 0078-0664 |
| APPLICATION NUMBER: | NDA207930 |
Other INDACATEROL MALEATE; GLYCOPYRROLATE Pharmaceutical Manufacturers / Labelers:
